Clinical Trials in San Antonio

Showing 11381-11400 of 12,572 trials

Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

NCT00538642

Having a diagnosis of schizophrenia or bipolar disorder and being treated with certain of the newer antipsychotics are risk factors for development of diabetes. Subjects with these risk factors plus obesity and/or family history of diabetes who agree to study participation will undergo an oral glucose tolerance test. If the oral glucose tolerance test demonstrates that the subject is pre-diabetic (elevated glucose levels, but below the diabetic range), he/she will have his/her insulin resistance level measured, prior to random assignment to either stay on current antipsychotic medication or switch to ziprasidone. Insulin resistance will be measured again after four months. The primary hypothesis is that insulin resistance will decrease in those switched to ziprasidone relative to those continuing on their same antipsychotic medication.

SchizophreniaSchizoaffective DisorderBipolar Disorder

The University of Texas Health Science Center at San Antonio24 participantsStarted Aug 2007

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

FS VH S/D 500 S-apr in Vascular Surgery

NCT00892957

The purpose of this study was to compare safety and efficacy of FS VH S/D 500 s-apr (FS) versus manual compression in prosthetic expanded polytetrafluoroethylene (ePTFE) graft placement.

Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses

Baxter Healthcare Corporation176 participantsStarted Jul 2009

Birmingham, Alabama, United States • Tucson, Arizona, United States • Fresno, California, United States +19 more locations

Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

FS VH S/D 500 S-apr in Vascular Surgery

Find Trials by Condition in San Antonio

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Ramelteon in Adults With Chronic Insomnia

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

Fibromyalgia Health Outcome Study on Cost of Treatments

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

A Phase 2 Study With IPI-926 in Patients With Myelofibrosis

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.